CLINICAL_TRIALS
trial_result
· 2023-09-28
Clinical Trial Update: Thyroid Hormone Supplementation in Patients With Septic Shock [Phase 2]
Summary
Phase 2 trial update on thyroid hormone supplementation in patients with euthyroid sick syndrome and septic shock has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cantonal Hospital Zenica | Conditions: Euthyroid Sick Syndromes, Septic Shock | Phase 2 | Status: COMPLETED